Abstract: The present invention discloses a detection device for detecting irregular intravascular pressure, the device including an analyzer for automatically analyzing intravascular pressure upstream of the suspected location of irregular blood flow, and a comparing device that correlates the recorded intravascular pressure to a standard whereby variation in the intravascular pressure during multiple tests is indicative of irregular blood flow. Also disclosed is a system for providing a warning of potential health problems due to irregular blood flow, the system including a detecting device as set forth above and a communicating device operatively connected to the detecting device for communicating a warning when the device indicates an irregularity of intravascular pressure during at least two uses of the device.

Abstract: A method for forming cascade polymers specifically utilizing the amine monomer of the formula The monomer is made by initially reacting nitromethane and CH2?CHCO2— TBu by nucleophilic addition to form the triester nitrotrialkanoate of the formula and then reducing the nitrosubstituent to afford the said amine monomer.

Abstract: siRNA molecules are disclosed which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells. The use of STAT6 specific siRNA molecules in the treatment of allergic diseases of the respiratory tract such as asthma and rhinitis is disclosed.

Abstract: The invention relates to an animal model for diabetes and a method for obtaining said animal model. The invention also relates to the uses of the animal model for screening for or testing compounds for treating or preventing diabetes symptoms. The invention further relates to an assay for determining an individual's susceptibility to developing diabetes. The invention also relates to nucleic acid molecules isolated from Ljungan virus and to polypeptides encoded by any portion of said nucleic acid molecule.

Abstract: An emulsion for preparing a low-conductivity surface for powder coating, the emulsion including an emulsified organofunctional silane solution. A pre-powder coating emulsion provides a surface with conductivity. A non-conductive object having applied to an exterior surface of the object the emulsion including an emulsified organofunctional silane solution.

Abstract: A method of making a vaccine using animal derived component free (ADCF) cell culture technology, including the steps of attaching ADCF-adapted cells to a microcarrier including an attachment mechanism for attaching filipodia of the cells, the microcarrier being in a culture, growing the cells in ADCF maintenance media, infecting the cells with vaccine media, producing virus within the cells, and harvesting the virus. A vaccine produced by the above method in a pharmaceutically acceptable carrier. A vaccine production structure of ADCF-adapted cells removably attached to microcarrier beads including an attachment mechanism for attaching filipodia of the cells.

Abstract: A method of screening for a protein involved in the extracellular regulation of latent TGF? activation by transducing a cell line with a retroviral cDNA library to create a reporter cell line that produces green fluorescent protein (GFP) in response to TGF-? signaling; growing individual clones created by the reporter cell line; co-culturing each individual clone with a second TGF-? reporter cell line that produces luciferase in response to TGF-?, wherein the luciferase production identifies positive clones; and identifying a mechanism of latent TGF-? activation that is employed by the positive clones. A TGF? reporter cell line including a cell line; and a retroviral cDNA library, wherein the reporter cell line produces GFP in response to TGF-? signaling. A method of screening for gene products involved in a biological process.

Abstract: A method of coating a carbon article with a metal by cyclic voltammetrically electrodepositing the metal on the carbon article, thereby forming a metal coating on the carbon article and the metal-coated carbon article made by the method. A metal-coated carbon article having a carbon article and a metal coating disposed on an exterior surface of the carbon article, the coating being present in an amount less than about 0.1 mg/cm2.

Abstract: According to the present invention, there is provided a documentation system including an augmenting mechanism that elicits more accurate conclusions through the analysis of entered information and predetermined criteria. The present invention also provides for a method of documentation based upon the augmenting mechanism and a method of augmenting to calculate more accurate conclusions based upon all entered information and related predetermined criteria. Additionally, the present invention includes a software program for operating the documentation system and method for the operation of the augmenting mechanism. The present invention provides for a computerized documentation entry system for determining more accurate conclusions including a software program having an augmenting mechanism and a graphic user interface for displaying, accessing and interacting with users of the documentation system.

Abstract: A method of prophylactic and/or therapeutic treatment of a mammal for a disease that is caused by a Ljungan virus infection, such as Myocarditis, Cardiomyopathia, Guillain Barré Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis, Amyothrophic Lateral Sclerosis, Dermatomyositis, Polymyositis, Spontaneous Abortion, Intrauterine Death, Preeclampsia, Sudden Infant Death Syndrome, Bell's (facial) paralysis, Addison's disease, and Pernicious anemia, is described. An antiviral compound effective against a Ljungan virus, such as a compound effective against a picornavirus, e.g. Pleconaril or a derivative thereof, is used for the preparation of a medicament for the treatment of a disease in a mammal that is caused by a Ljungan virus infection, to eliminate or inhibit proliferation of the virus in the mammal and at the same time prevent and/or treat the disease in the mammal.

Abstract: A disposable sanitary gauge tee with no dead zone for use in pressure measurement of fluid in disposable tubing including a body having a main fluid passageway in fluid connection with a proximal end of a pressure fluid passageway, the main fluid passageway including a fluid port and a second fluid port, wherein a hose barb is operatively attached to the body at the fluid port and the second fluid port, wherein the disposable tubing can be removably attached to the hose barbs, and the pressure fluid passageway including a distal end for removable attachment of a sanitary pressure gauge and a biocompatible gauge protector for isolation of the fluid from the sanitary pressure gauge. No dead zone is achieved within the gauge tee as the proximal end of the pressure fluid passageway is substantially the same diameter as the distal end of the pressure fluid passageway, therein providing a total transfer of fluid within the pressure fluid passageway during fluid flow.

Abstract: A method of detecting unreacted termini within a dendritic structure is achieved by exposing a dendrimer to a single generating compound capable of bonding to and tagging a deprotected but uncoupled termini. A signal generated by the signal generating compound to an otherwise uncoupled termini provides detection of the unreacted termini.

Abstract: The pump includes a metering pump including a rotor, at least two lengths of tubing against which the rotor is movable to urge the drug therethrough, and an outlet port associated with each of the at least two lengths of tubing. In this way, a drug may be supplied to more than one neurological target.

Abstract: The pump includes a metering pump including a rotor, at least two lengths of tubing against which the rotor is movable to urge the drug therethrough, and an outlet port associated with each of the at least two lengths of tubing. In this way, a drug may be supplied to more than one neurological target.

Abstract: The present invention relates to apparatus for use in neurosurgery, and to a method of positioning neurosurgical apparatus. The stereoguide comprises first and second guide elements through which instruments are passed along an axis of insertion towards a target and a first clamp (25) having a clamping position on the axis between the guide elements and the target.

Abstract: Methods for preparing viral neuraminidase inhibitors including antiviral peptides by specifically chemically modifying disulfide bonds in precursor molecules. A method of inhibiting viral neuraminidases by administering a viral neuraminidase inhibitor comprising an antiviral peptide prepared by the above methods and inhibiting the viral neuraminidase. Therapeutics for inhibiting viral neuraminidases, including effective amounts of viral neuraminidase inhibitors including antiviral peptides derived from selectively chemically modified disulfide bonds in precursor molecules, and present in a pharmaceutically acceptable carriers.

Abstract: A compound consists of a fractal-like, plain or organometallic array useful for energy storage devices. A dendrimer useful in the synthesis of the fractal-like compound includes a single ligating moiety bound to a surface of each quadrant of the dendrimer. A method of making metallo-based (macro) molecules includes the steps of combining monomers selected from the group consisting of bipyridal- and terpyridal-based ligands with connecting metals and self assembling macrocycles wherein the monomes are interconnected by the metals.

Abstract: According to the present invention, there is provided a delivery vehicle including sickle red blood cells carrying a moiety. The moiety can be any type of diagnostic or therapeutic agent. The present invention further provides for a method of diagnosing systemic hypoxia, acidosis, or hypertonicity by administering sickle red blood cells to a patient and detecting the location of the sickle red blood cells. Additionally, the present invention provides for a method of therapeutic treatment of systemic hypoxia, acidosis, or hypertonicity by administering sickle red blood cells to a patient. Further, the present invention provides for a delivery vehicle that specifically localizes or concentrates at systemic hypoxia, acidosis, or hypertonicity areas. The delivery vehicle is used in diagnosing and therapeutically treating these areas of hypoxia, acidosis, or hypertonicity also. The present invention further provides for a method of making the delivery vehicle described herein.

Abstract: An adjustable clamping tong including a moveable pivoting clamping plate mechanism; a fixed clamping plate mechanism; and a guide mechanism for guiding the moveable pivoting clamping plate mechanism at a distal end of the guide mechanism and for fixing the fixed clamping plate mechanism at a proximal end of the guide mechanism, wherein the moveable pivoting clamping plate mechanism moves co-axially along the guide mechanism and pivots in multiple directions relative to the guide mechanism. An adjustable clamping tong including a pivoting clamping plate mechanism; a fixed clamping plate mechanism; and a spacing mechanism for spacing the pivoting clamping plate mechanism at a distal end of the spacing mechanism from the fixed clamping plate mechanism at a proximal end of the spacing mechanism, wherein the spacing mechanism includes an adjusting mechanism and the pivoting clamping plate mechanism axially pivots along the spacing mechanism.

Abstract: There is provided a method of augmenting transient protein synthesis in a cell by delivering to the cell mRNA functionally related to protein production. Also provided is a method of augmenting transient protein synthesis in cells by increasing protein synthesis of growth factors from endogenous cellular mRNA and exogenous mRNA delivered to the cells. A treatment for transiently increasing protein production in cells, said treatment comprising mRNA functionally related to protein production is also provided. There is provided a method of augmenting wound healing by delivering mRNA functionally related to wound healing. Further provided is a therapeutic for transiently increasing protein synthesis in cells, said therapeutic comprising mRNA related to protein production.